| Stage | VRSN | % of rev | CTSH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $443M | 100.00% | $5.7B | 100.00% | CTSH ×12.79 |
| Gross profit | $393M | 88.76% | $1.9B | 33.77% | VRSN +55.0pp |
| Operating income | $297M | 66.93% | $872M | 15.40% | VRSN +51.5pp |
| Pre-tax income | $280M | 63.12% | $863M | 15.24% | VRSN +47.9pp |
| Net income | $213M | 47.99% | $627M | 11.07% | VRSN +36.9pp |
| Stage | VRSN | CTSH | Gap · A − B |
|---|---|---|---|
| Revenue | $443M100.00% | $5.7B100.00% | CTSH ×12.79 |
| Gross profit | 88.76%$393M | 33.77%$1.9B | VRSN +55.0pp |
| Operating income | 66.93%$297M | 15.40%$872M | VRSN +51.5pp |
| Pre-tax income | 63.12%$280M | 15.24%$863M | VRSN +47.9pp |
| Net income |
| 47.99%$213M |
| 11.07%$627M |
| VRSN +36.9pp |